Pubblicazioni

Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis

2022 - ANTICANCER RESEARCH

DE Felice, Francesca; Musio, Daniela; Iafrate, Franco; Caponnetto, Salvatore; Picone, Vincenzo; D'Ambrosio, Giancarlo; Magliocca, Fabio Massimo; Tozzi, Francesca; DE Toma, Giorgio; Tombolini, Vincenzo; Cortesi, Enrico

Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia

2021 - NEW ENGLAND JOURNAL OF MEDICINE

Tiacci, E.; De Carolis, L.; Simonetti, E.; Capponi, M.; Ambrosetti, A.; Lucia, E.; Antolino, A.; Pulsoni, A.; Ferrari, S.; Zinzani, P. L.; Ascani, S.; Perriello, V. M.; Rigacci, L.; Gaidano, G.; Seta, R. D.; Frattarelli, N.; Falcucci, P.; Foa, R.; Visani, G.; Zaja, F.; Falini, B.

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial

2021 - THE LANCET. HAEMATOLOGY

Ladetto, M.; Cortelazzo, S.; Ferrero, S.; Evangelista, A.; Mian, M.; Tavarozzi, R.; Zanni, M.; Cavallo, F.; Di Rocco, A.; Stefoni, V.; Pagani, C.; Re, A.; Chiappella, A.; Balzarotti, M.; Zilioli, V. R.; Gomes da Silva, M.; Arcaini, L.; Molinari, A. L.; Ballerini, F.; Ferreri, A. J. M.; Puccini, B.; Benedetti, F.; Stefani, P. M.; Narni, F.; Casaroli, I.; Stelitano, C.; Ciccone, G.; Vitolo, U.; Martelli, M.

Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial

2021 - JAMA ONCOLOGY

Martinelli, E.; Martini, G.; Famiglietti, V.; Troiani, T.; Napolitano, S.; Pietrantonio, F.; Ciardiello, D.; Terminiello, M.; Borrelli, C.; Vitiello, P. P.; De Braud, F.; Morano, F.; Avallone, A.; Normanno, N.; Nappi, A.; Maiello, E.; Latiano, T.; Falcone, A.; Cremolini, C.; Rossini, D.; Santabarbara, G.; Pinto, C.; Santini, D.; Cardone, C.; Zanaletti, N.; Di Liello, A.; Renato, D.; Esposito, L.; Marrone, F.; Ciardiello, F.

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)

2021 - AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS

Santini, D; Stellato, M; De Giorgi, U; Pantano, F; De Lisi, D; Casadei, C; Maruzzo, M; Bimbatti, D; Naglieri, E; Buti, S; Bersanelli, M; De Vivo, R; Di Lorenzo, G; Sbrana, A; Verzoni, E; Soraru', M; Fornarini, G; Mucciarini, C; Grillone, F; Mini, E; Vignani, F; Attademo, L; Pignata, S; Procopio, G

Multiple and Concomitant Molecular Findings in a Heavily Treated Patient With EGFR-positive Lung Cancer

2021 - CLINICAL LUNG CANCER

Citarella, F.; Russano, M.; Galletti, A.; Vincenzi, B.; Tonini, G.; Santini, D.

Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The tetris trial

2021 - INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

Krasniqi, E.; Pizzuti, L.; Valerio, M. R.; Capomolla, E.; Botti, C.; Sanguineti, G.; Marchetti, P.; Anselmi, E.; Tomao, S.; Giordano, A.; Ficorella, C.; Cannita, K.; Livi, L.; Meattini, I.; Mauri, M.; Greco, F.; Veltri, E. M.; Michelotti, A.; Moscetti, L.; Giotta, F.; Lorusso, V.; Paris, I.; Tomao, F.; Santini, D.; Tonini, G.; Villa, A.; Gebbia, V.; Gamucci, T.; Ciliberto, G.; Sperduti, I.; Mazzotta, M.; Barba, M.; Vici, P.

CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies

2021 - BRITISH JOURNAL OF CANCER

Moretto, R.; Rossini, D.; Conca, V.; Lonardi, S.; Rasola, C.; Antoniotti, C.; Santini, D.; Marmorino, F.; Tomasello, G.; Borelli, B.; Caponnetto, S.; Zucchelli, G.; Zaniboni, A.; Ambrosini, M.; Buonadonna, A.; Fanchini, L.; Cupini, S.; Masi, G.; Falcone, A.; Cremolini, C.

Resection or stenting in the treatment of symptomatic advanced metastatic rectal cancer. A dilemma

2019 - ANTICANCER RESEARCH

Fiori, E.; Crocetti, D.; Lamazza, A.; De Felice, F.; Tarallo, M.; Sterpetti, A. V.; Mingoli, A.; Sapienza, P.; De Toma, G.

Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma

2019 - ANNALS OF HEMATOLOGY

Serrao, A.; Canichella, M.; De Luca, M. L.; Tartaglia, G.; Annechini, G.; D'Elia, G. M.; Pulsoni, A.

Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment

2019 - LEUKEMIA RESEARCH

Prezzo, A.; Cavaliere, F. M.; Bilotta, C.; Pentimalli, T. M.; Iacobini, M.; Cesini, L.; Foa, R.; Mauro, F. R.; Quinti, I.

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial

2019 - JAMA ONCOLOGY

Cremolini, C; Rossini, D; Dell'Aquila, E; Lonardi, S; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Danesi, R; Aprile, G; Tamburini, E; Barone, C; Masi, G; Pantano, F; Pucci, F; Corsi, Dc; Pella, N; Bergamo, F; Rofi, E; Barbara, C; Falcone, A; Santini, D

Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma

2018 - NEW ENGLAND JOURNAL OF MEDICINE

Mateos, M. -V.; Dimopoulos, M. A.; Cavo, M.; Suzuki, K.; Jakubowiak, A.; Knop, S.; Doyen, C.; Lucio, P.; Nagy, Z.; Kaplan, P.; Pour, L.; Cook, M.; Grosicki, S.; Crepaldi, A.; Liberati, A. M.; Campbell, P.; Shelekhova, T.; Yoon, S. -S.; Iosava, G.; Fujisaki, T.; Garg, M.; Chiu, C.; Wang, J.; Carson, R.; Crist, W.; Deraedt, W.; Nguyen, H.; Qi, M.; San-Miguel, J.; Foa, R.

Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy

2018 - ANNALS OF HEMATOLOGY

Cicconi, L; Breccia, M; Franceschini, L; Latagliata, R; Molica, M; Divona, M; Diverio, D; Rizzo, M; Ottone, T; Iaccarino, L; Alfonso, V; Foa, R; Voso, Mt; Lo-Coco, F

Complete resection of the hepatic veins: The role of right inferior vein

2018 - HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL

Felli, Emanuele; Meniconi, Roberto L.; Colasanti, Marco; Vennarecci, Giovanni; Ettorre, Giuseppe M.

Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases

2018 - EUROPEAN JOURNAL OF SURGICAL ONCOLOGY

Berardi, Giammauro; De Man, Marc; Laurent, StÃ©phanie; Smeets, Peter; Tomassini, Federico; Ariotti, Riccardo; Hoorens, Anne; van Dorpe, Jo; Varin, Oswald; Geboes, Karen; Troisi, Roberto I

Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis

2018 - PANCREAS

Brunetti, O.; Aprile, G.; Marchetti, P.; Vasile, E.; Casadei Gardini, A.; Scartozzi, M.; Barni, S.; Delfanti, S.; De Vita, F.; Di Costanzo, F.; Milella, M.; Cella, C. A.; Berardi, R.; Cataldo, I.; Scarpa, A.; Basile, D.; Mazzuca, F.; Graziano, G.; Argentiero, A.; Santini, D.; Reni, M.; Cascinu, S.; Silvestris, N.

Dabrafenib-trametinib combination in 'field-practice': An Italian experience

2018 - FUTURE ONCOLOGY

Depenni, R.; De Rosa, F.; Greco, S.; Ridolfi, L.; Pellacani, G.; Ponti, G.; Cascinu, S.; Guidoboni, M.

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

2017 - THE LANCET ONCOLOGY

Gronchi, Alessandro; Ferrari, Stefano; Quagliuolo, Vittorio; Broto, Javier Martin; Pousa, Antonio Lopez; Grignani, Giovanni; Basso, Umberto; Blay, Jean-Yves; Tendero, Oscar; Beveridge, Robert Diaz; Ferraresi, Virginia; Lugowska, Iwona; Merlo, Domenico Franco; Fontana, Valeria; Marchesi, Emanuela; Donati, Davide Maria; Palassini, Elena; Palmerini, Emanuela; De Sanctis, Rita; Morosi, Carlo; Stacchiotti, Silvia; BaguÃ£Â©, Silvia; Coindre, Jean Michelle; Dei Tos, Angelo Paolo; Picci, Piero; Bruzzi, Paolo; Casali, Paolo Giovanni

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial

2017 - JOURNAL OF CLINICAL ONCOLOGY

Platzbecker, Uwe; Avvisati, Giuseppe; Cicconi, Laura; Thiede, Christian; Paoloni, Francesca; Vignetti, Marco; Ferrara, Felicetto; Divona, Mariadomenica; Albano, Francesco; Efficace, Fabio; Fazi, Paola; Sborgia, Marco; Di Bona, Eros; Breccia, Massimo; Borlenghi, Erika; Cairoli, Roberto; Rambaldi, Alessandro; Melillo, Lorella; La Nasa, Giorgio; Fiedler, Walter; Brossart, Peter; Hertenstein, Bernd; Salih, Helmut R.; Wattad, Mohammed; LÃ¼bbert, Michael; Brandts, Christian H.; HÃ¤nel, Mathias; RÃ¶llig, Christoph; Schmitz, Norbert; Link, Hartmut; Frairia, Chiara; Pogliani, Enrico Maria; Fozza, Claudio; D'Arco, Alfonso Maria; Di Renzo, Nicola; Cortelezzi, Agostino; Fabbiano, Francesco; DÃ¶hner, Konstanze; Ganser, Arnold; DÃ¶hner, Hartmut; Amadori, Sergio; Mandelli, Franco; Ehninger, Gerhard; Schlenk, Richard F.; Lo-Coco, Francesco

Neoadjuvant sequential docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial

2016 - JOURNAL OF CELLULAR PHYSIOLOGY

Pizzuti, Laura; Barba, Maddalena; Giannarelli, Diana; Sergi, Domenico; Botti, Claudio; Marchetti, Paolo; AnzÃ , Michele; Maugeri SaccÃ , Marcello; Natoli, Clara; DI FILIPPO, Simona; Catenaro, Teresa; Tomao, Federica; Amodio, Antonella; Carpano, Silvia; Perracchio, Letizia; Mottolese, Marcella; Di Lauro, Luigi; Sanguineti, Giuseppe; Di Benedetto, Anna; Giordano, Antonio; Vici, Patrizia

Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma: Final results of a multicenter phase II study

2016 - JOURNAL OF CLINICAL ONCOLOGY

Santoro, Armando; Mazza, Rita; Pulsoni, Alessandro; Re, Alessandro; Bonfichi, Maurizio; Zilioli, Vittorio Ruggero; Salvi, Flavia; Merli, Francesco; Anastasia, Antonella; Luminari, Stefano; Annechini, Giorgia; Gotti, Manuel; Peli, Annalisa; Liberati, Anna Marina; Di Renzo, Nicola; Castagna, Luca; Giordano, Laura; Carlo-Stella, Carmelo